# Remifentanil Dosing Regimes for Anesthesia in Bariatric Surgery: Characteristics of Early Recovery

> **NCT04690088** · — · COMPLETED · sponsor: **Lithuanian University of Health Sciences** · enrollment: 31 (actual)

## Conditions studied

- Morbid Obesity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04690088
- **Lead sponsor:** Lithuanian University of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-10
- **Primary completion:** 2019-12-01
- **Final completion:** 2020-02-10
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2020-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04690088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04690088, "Remifentanil Dosing Regimes for Anesthesia in Bariatric Surgery: Characteristics of Early Recovery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04690088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*